PMC:7205724 / 343-531 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"7","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"10","span":{"begin":84,"end":87},"obj":"Gene"},{"id":"11","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"20","span":{"begin":169,"end":180},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:C000657245"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"Gene:3569"},{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"MESH:C000657245"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"T4","span":{"begin":156,"end":164},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":51,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T2","span":{"begin":127,"end":137},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062178"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T4","span":{"begin":51,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T3","span":{"begin":71,"end":79},"obj":"Species"},{"id":"T4","span":{"begin":156,"end":164},"obj":"Species"}],"attributes":[{"id":"A3","pred":"ncbi_taxonomy_id","subj":"T3","obj":"NCBItxid:2697049"},{"id":"A4","pred":"ncbi_taxonomy_id","subj":"T4","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T8","span":{"begin":81,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"7","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"10","span":{"begin":84,"end":87},"obj":"Gene"},{"id":"11","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"20","span":{"begin":169,"end":180},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"pubann:denotes","subj":"7","obj":"MESH:C000657245"},{"id":"A10","pred":"pubann:denotes","subj":"10","obj":"Gene:3569"},{"id":"A11","pred":"pubann:denotes","subj":"11","obj":"MESH:C000657245"},{"id":"A20","pred":"pubann:denotes","subj":"20","obj":"MESH:C502936"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T1","span":{"begin":84,"end":87},"obj":"Protein"}],"attributes":[{"id":"A1","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A2","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A3","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A4","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A5","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A6","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A7","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A8","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A9","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A10","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A11","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A12","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A13","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A14","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A15","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A16","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A17","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A18","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A19","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A20","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A21","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A22","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A23","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A24","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A25","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A26","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A27","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A28","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A29","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A30","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A31","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A32","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A33","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A34","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A35","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A36","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A37","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A38","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A39","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A40","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A41","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A42","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A43","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A44","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T48","span":{"begin":1,"end":3},"obj":"DT"},{"id":"T49","span":{"begin":4,"end":14},"obj":"VBN"},{"id":"T50","span":{"begin":15,"end":23},"obj":"JJ"},{"id":"T51","span":{"begin":24,"end":30},"obj":"NNS"},{"id":"T52","span":{"begin":31,"end":36},"obj":"VBP"},{"id":"T53","span":{"begin":37,"end":39},"obj":"IN"},{"id":"T54","span":{"begin":40,"end":43},"obj":"DT"},{"id":"T55","span":{"begin":44,"end":47},"obj":"NN"},{"id":"T56","span":{"begin":48,"end":50},"obj":"IN"},{"id":"T57","span":{"begin":51,"end":66},"obj":"NNS"},{"id":"T58","span":{"begin":67,"end":70},"obj":"IN"},{"id":"T59","span":{"begin":71,"end":79},"obj":"NN"},{"id":"T60","span":{"begin":81,"end":82},"obj":"LS"},{"id":"T61","span":{"begin":84,"end":87},"obj":"NN"},{"id":"T62","span":{"begin":88,"end":98},"obj":"VBZ"},{"id":"T63","span":{"begin":99,"end":103},"obj":"IN"},{"id":"T64","span":{"begin":104,"end":112},"obj":"NN"},{"id":"T65","span":{"begin":112,"end":113},"obj":"-COMMA-"},{"id":"T66","span":{"begin":114,"end":125},"obj":"NN"},{"id":"T67","span":{"begin":125,"end":126},"obj":"-COMMA-"},{"id":"T68","span":{"begin":127,"end":132},"obj":"JJ"},{"id":"T69","span":{"begin":133,"end":137},"obj":"NN"},{"id":"T70","span":{"begin":137,"end":138},"obj":"-COMMA-"},{"id":"T71","span":{"begin":139,"end":142},"obj":"CC"},{"id":"T72","span":{"begin":143,"end":152},"obj":"NN"},{"id":"T73","span":{"begin":153,"end":155},"obj":"IN"},{"id":"T74","span":{"begin":156,"end":164},"obj":"NN"},{"id":"T75","span":{"begin":166,"end":167},"obj":"IN"},{"id":"T76","span":{"begin":169,"end":180},"obj":"NNP"},{"id":"T77","span":{"begin":180,"end":181},"obj":"-COMMA-"},{"id":"T78","span":{"begin":182,"end":184},"obj":"DT"}],"relations":[{"id":"R44","pred":"arg1Of","subj":"T51","obj":"T48"},{"id":"R45","pred":"arg2Of","subj":"T51","obj":"T49"},{"id":"R46","pred":"arg1Of","subj":"T51","obj":"T50"},{"id":"R47","pred":"arg1Of","subj":"T51","obj":"T52"},{"id":"R48","pred":"arg1Of","subj":"T52","obj":"T53"},{"id":"R49","pred":"arg2Of","subj":"T55","obj":"T53"},{"id":"R50","pred":"arg1Of","subj":"T55","obj":"T54"},{"id":"R51","pred":"arg1Of","subj":"T55","obj":"T56"},{"id":"R52","pred":"arg2Of","subj":"T57","obj":"T56"},{"id":"R53","pred":"arg1Of","subj":"T55","obj":"T58"},{"id":"R54","pred":"arg2Of","subj":"T59","obj":"T58"},{"id":"R55","pred":"arg1Of","subj":"T62","obj":"T60"},{"id":"R56","pred":"arg1Of","subj":"T61","obj":"T62"},{"id":"R57","pred":"arg1Of","subj":"T62","obj":"T63"},{"id":"R58","pred":"arg2Of","subj":"T71","obj":"T63"},{"id":"R59","pred":"arg1Of","subj":"T64","obj":"T65"},{"id":"R60","pred":"arg2Of","subj":"T66","obj":"T65"},{"id":"R61","pred":"arg1Of","subj":"T65","obj":"T67"},{"id":"R62","pred":"arg2Of","subj":"T69","obj":"T67"},{"id":"R63","pred":"arg1Of","subj":"T69","obj":"T68"},{"id":"R64","pred":"arg1Of","subj":"T71","obj":"T70"},{"id":"R65","pred":"arg1Of","subj":"T67","obj":"T71"},{"id":"R66","pred":"arg2Of","subj":"T72","obj":"T71"},{"id":"R67","pred":"arg1Of","subj":"T72","obj":"T73"},{"id":"R68","pred":"arg2Of","subj":"T74","obj":"T73"},{"id":"R70","pred":"arg1Of","subj":"T76","obj":"T77"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T3","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"T4","span":{"begin":156,"end":164},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":81,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.\n• Tocilizumab, an ant"}